Fibroblasten-Interferon-Therapie (Hu IFN-β) bei Non-Hodgkin-Lymphomen (NHL) mit niedrigem Malignitätsgrad: Vorläufige Ergebnisse.

Autor: Fink, U., Siegert, W., Huhn, D., Wilmanns, W., Berdel, W., Emmerich, B., Hutsteiner, H., Wüst, I., Rastetter, J., Theml, H., Riethmüller, G.
Zdroj: Blut: Zeitschrift für die Gesamte Blutforschung; 1982, Vol. 44 Issue 2, p121-124, 4p
Abstrakt: Preliminary results of a cooperative pilot study on the effect of fibroblast interferon in 10 patients with NHL of low-grade malignancy are presented. In eight patients lymphoma progression forced a discontinuation of therapy. At the end of interferon treatment one patient with CBCC showed a stable disease, one patient with CBCC a minor partial remission. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index